USA Today reports:
Texas has run out of its supply of monoclonal antibodies, and infusion centers in the state will be unable to offer the treatment until more shipments are sent out in January.
Infusion centers in Austin, El Paso, Fort Worth, San Antonio and The Woodlands have all gone through their supply of sotrovimab, the only antibody treatment believed to be effective against the omicron variant, the Texas Health and Human Services Commission said on Monday.
The agency said infusion centers in Texas will be unable to offer the treatment until “federal authorities ship additional courses of sotrovimab to Texas in January.”
Read the full article.
The monoclonal antibody sotrovimab has been shown to be effective against omicron, while other antibodies have not been shown to be effective against the variant.https://t.co/0OclCmfAoF
— USA TODAY (@USATODAY) December 28, 2021